A new truth is not more harmful than an old error: Agreements of new guidelines on opioid treatment for chronic pain with the prognoses of effectiveness by the DGSS S3 guideline LONTS;Einer neuen Wahrheit ist nichts schädlicher als ein alter Irrtum: Übereinstimmungen neuer Leitlinien zur Opioidanwendung bei chronischen Schmerzen mit den Wirkprognosen der DGSS S3-LeitIinie LONTS

Schmerz

Volumn 24, Issue 4, 2010, Pages 309-312

  Sorgatz, H ^a   Maier, C ^b  

^a DARMSTADT UNIVERSITY OF TECHNOLOGY   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GABAPENTIN; OPIATE; PLACEBO;

CHRONIC PAIN; CLINICAL TRIAL; EDITORIAL; GOLD STANDARD; HUMAN; NEUROPATHIC PAIN; PRESCRIPTION;

ANALGESICS, OPIOID; CHRONIC DISEASE; HUMANS; PAIN; PRACTICE GUIDELINES AS TOPIC; PROGNOSIS;

EID: 78049371006     PISSN: 0932433X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00482-010-0946-7     Document Type: Editorial

References (36)

1. DGSS Leitlinien Kommission (2009) S3-Leitlinie Langzeitanwendung von Opioiden bei nicht tu-morbedingten Schmerzen (LONTS). http://www.uni- duesseldorf.de/AWMF/ll/041-003.htm
2. Reinecke H, Sorgatz H (2009) S3-Leitlinie LONTS. Schmerz 23:440-447
3. National Opioid Use Guideline Group (2010) Cana-dian guideline for safe and effective use of opioids for chronic non-cancer pain. http://nationalpain- centre.mcmaster.ca/opioid/
4. Chou R, Fanciullo GJ, Fine PG et al (2009) Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain 10(2):113-130
5. Trescot AM, Helm S, Hansen H et al (2008) Opioi-ds in the management of chronic non-cancer pain: an update of American Society of the Interventio-nal Pain Physicians' (ASIPP) guidelines. Pain Physi-cian 11:S5-S62
6. BPS - The British Pain Society (2010) Opioids for persistent pain: good practice. http://www.british-painsociety.org/book-opioid-main.pdf
7. Chou R, Ballantyne JC, Fanciullo GJ et al (2009) Re-search gaps on use of opioids for chronic noncan-cer pain: findings from a review of the evidence for an American Pain Society and American Academy of Pain Medicine Clinical Practice Guideline. J Pain 10(2):147-159
8. Dworkin RH, Turk DC, McDermott MP et al (2009) Interpreting the clinical importance of group dif-ferences in chronic pain clinical trials: IMMPACT re-commendations. Pain 146(3):238-244
9. Trescot AM, Glaser SE, Hansen H et al (2008) Ef-fectiveness of opioids in the treatment of chronic non-cancer-pain. Pain Physician 11:S181-S200
10. Noble M, Tregear SJ, Treadwell JR et al (2008) Long-term opioid therapy for chronic noncan-cer pain: a systematic review and meta-analy-sis of efficacy and safety. J Pain Symptom Manage 35(2):214-228
11. Noble M, Treadwell JR, Tregear SJ et al (2010) Long-term opioid management for chronic non-cancer pain. Cochrane Database Syst Rev 20(1):CD006605
12. Dillie KS, Fleming MF, Mundt MP et al (2008) Qua-lity of life associated with daily opioid therapy in a primary care chronic pain sample. J Am Board Fam Med 21(2):108-117
13. Sullivan MD, Von Korff M, Banta-Green c et al (2010) Problems and concerns of patients recei-ving chronic opioid therapy for chronic non-cancer pain. Pain 149(2):345-353
14. Miettinen OS (1998) Evidence in medicine: invited commentary. CMAJ 158(2):215-221
15. Ankier SI (2002) Dishonesty, misconduct and fraud in clinical research: an international problem. J Int Med Res 30:357-65
16. Chan AW, Hróbjartsson A, Haahr MT et al (2004) Empirical evidence for selective reporting of out-comes in randomized trials: comparison of pro-tocols to published articles. JAMA 291(20):2457-2465
17. Kirkham JJ, Dwan KM, Altman DG et al (2010) The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews. BMJ 340:c365
18. Gøtzsche PC, Hróbjatsson A, Marić KL et al (2007) Data extraction errors in meta-analyses that use standardized mean differences. JAMA 298(4):430-437
19. Ford AC, Guyatt Gh, Talley NJ et al (2010) Errors in the conduct of systematic reviews of pharmacolo-gical interventions for irritable bowel syndrome. Am J Gastroenterol 105(2):280-288
20. Tendal B, Higgins JP, Jüni P (2009) Disagreements in meta-analyses using outcomes measured on continuous or rating scales: observer agreement study. BMJ 339:b3128-b3128
21. Verband forschender Arzneimittelhersteller (2010) Positionspapier "Publication bias". http://www.vfa.de/download/SHOW/de/politik/ positionen/pos-publication-bias.html/pos-publication-bias.pdf
22. Schott G; Pachl H, Limbach U et al (2010) "Finan-zierung von Arzneimittelstudien durch pharma-zeutische Unternehmen und die Folgen" Dtsch Arztebl Int 107:279-85 und 107:295-301
23. Vedula SS, Bero L, Scherer RW, Dickersin K (2009) Outcome reporting in industry-sponsored tri-als of gabapentin for off-label use. N Eng J Med 361:1963-1971
24. Turner EH, Matthews AM, Linardatos E et al (2008) Selective publication of antidepressant trials and its influence on apparent efficacy. N Eng J Med 358:252-260
25. Black N (1996) Why we need observational studies to evaluate the effectiveness of health care. BMJ 312:1215-1218
26. De Williams AC, Nicholas MK, Richardson PH et al (1999) Generalizing from a controlled trial: the ef-fects of patient preference versus randomization on the outcome of inpatient versus outpatient ch-ronic pain management. Pain 83:57-65
27. Yuval R, Uziel K, Gordon N et al (2001) Perceived benefit after participating in positive or negative/neutral heart failure trials: the patients' perspec-tive. Eur J Heart Fail 3:217-23
28. Horwitz RI, Horwitz SM (1993) Adherence to treat-ment and health outcomes. Arch Intern Med 53:1863-1868
29. Chapman CR, Lipschitz DL, Angst MS et al (2010) Opioid pharmacotherapy for chronic non-cancer pain in the United States: a research guideline for developing an evidence-base. J Pain (in press)
30. Grootendorst DV, Jager KJ, Zoccali C et al (2010) Observational studies are complementary to ran-domized controlled trials. Nephron Clin Pract 114:c173-c177
31. Hamunen K, Paakkari P, Kalso E (2009) Trends in opioid consumption in the Nordic countries 2002-2006. Eur J Pain 13:954-962
32. Maier C (2008) Auch Sucht ist eine Krankheit. Schmerz 22:639-643
33. Ballantyne JC, LaForge KS (2007). Opioid depen-dence and addiction during opioid treatment of chronic pain. Pain 129:235-255
34. Fredheim OM, Skurtveit S, Breivik H et al (2010) In-creasing use of opioids from 2004 to 2007 - Phar-macoepidemiological data from a complete nati-onal prescription database in Norway. Eur J Pain 14:289-94
35. Eriksen J, Sjøgren P, Bruera E et al (2006) Critical is-sues on opioids in chronic non-cancer pain: an epi-demiological study. Pain 125:172-9
36. Cicero TJ, Lynskey M, Todorov A et al (2008) Co-morbid pain and psychopathology in males and females admitted to treatment for opioid analge-sic abuse. Pain 139:127-35